Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymph Node-negative”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Not applicableStudy completedNCT00115505
What this trial is testing

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

Who this might be right for
Breast Carcinoma
Alliance for Clinical Trials in Oncology 307
Large-scale testing (Phase 3)Looking for participantsNCT06704945
What this trial is testing

No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy

Who this might be right for
Breast CancerNeoadjuvant TherapySentinel Lymph Node Biopsy
Seoul National University Hospital 464
Large-scale testing (Phase 3)Study completedNCT00003830
What this trial is testing

Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 5,611
Testing effectiveness (Phase 2)UnknownNCT02294565
What this trial is testing

VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Vestan, Inc. 147
Not applicableLooking for participantsNCT07622836
What this trial is testing

A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.

Who this might be right for
TNBCAdjuvant TherapyLymph Node Positive
The First Affiliated Hospital with Nanjing Medical University 59
Testing effectiveness (Phase 2)UnknownNCT04659499
What this trial is testing

Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer

Who this might be right for
Early Breast Cancer
Peking Union Medical College Hospital 261
Not applicableStudy completedNCT01276899
What this trial is testing

Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Jewish General Hospital 80
Not applicableStudy completedNCT02031042
What this trial is testing

Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Stockholm South General Hospital 224
Not applicableStudy completedNCT02266420
What this trial is testing

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm

Who this might be right for
Triple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mm
Institut Claudius Regaud 151
Not applicableNot Yet RecruitingNCT07573397
What this trial is testing

A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Fudan University 88
Large-scale testing (Phase 3)Active Not RecruitingNCT00798070
What this trial is testing

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients

Who this might be right for
Breast Cancer
Karolinska University Hospital 2,017
Not applicableStudy completedNCT00282035
What this trial is testing

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Who this might be right for
Breast Cancer
Ontario Clinical Oncology Group (OCOG) 2,135
Not applicableLooking for participantsNCT07546695
What this trial is testing

Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study

Who this might be right for
Breast Cancer
University Hospital, Basel, Switzerland 600
Not applicableUnknownNCT03374826
What this trial is testing

PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients

Who this might be right for
Breast CancerBreast NeoplasmsBreast Diseases
Maastricht University Medical Center 125
Testing effectiveness (Phase 2)Study completedNCT01642511
What this trial is testing

Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 407
Not applicableLooking for participantsNCT06776172
What this trial is testing

Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.

Who this might be right for
Prostate Cancer SurgeryProstate Cancers
University Hospital, Basel, Switzerland 400
Early research (Phase 1)Looking for participantsNCT06121557
What this trial is testing

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 24
Testing effectiveness (Phase 2)Looking for participantsNCT05981001
What this trial is testing

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 170
Large-scale testing (Phase 3)Study completedNCT00309478
What this trial is testing

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

Who this might be right for
Early-stage Breast Cancer
Austrian Breast & Colorectal Cancer Study Group 1,099
Not applicableLooking for participantsNCT06711068
What this trial is testing

Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy

Who this might be right for
HER2-positive Breast Cancer
Shu Wang 8,077
Load More Results